These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1352811)

  • 21. Biomembrane model interaction and percutaneous absorption of papaverine through rat skin: effects of cyclodextrins as penetration enhancers.
    Ventura CA; Fresta M; Paolino D; Pedotti S; Corsaro A; Puglisi G
    J Drug Target; 2001; 9(5):379-93. PubMed ID: 11770707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of vehicles and penetration enhancers on the in vitro and in vivo percutaneous absorption of methotrexate and edatrexate through hairless mouse skin.
    Chatterjee DJ; Li WY; Koda RT
    Pharm Res; 1997 Aug; 14(8):1058-65. PubMed ID: 9279889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclodextrins as co-enhancers in dermal and transdermal drug delivery.
    Loftsson T; Másson M; Sigurdsson HH; Magnússon P; Le Goffic F
    Pharmazie; 1998 Feb; 53(2):137-9. PubMed ID: 9540112
    [No Abstract]   [Full Text] [Related]  

  • 24. [Improvement of stability and bioavailability of 1-hexylcarbamoyl-5-fluorouracil (HCFU) by O-carboxymethyl-O-ethyl-beta- cyclodextrin].
    Horiuchi Y; Hirayama F; Uekama K
    Yakugaku Zasshi; 1991 Oct; 111(10):592-9. PubMed ID: 1812279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse.
    Bentley MV; Vianna RF; Wilson S; Collett JH
    J Pharm Pharmacol; 1997 Apr; 49(4):397-402. PubMed ID: 9232537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcutaneous delivery of prostaglandin E1: in vitro and laser doppler flowmetry study.
    Foldvari M; Oguejiofor CJ; Wilson TW; Afridi SK; Kudel TA
    J Pharm Sci; 1998 Jun; 87(6):721-5. PubMed ID: 9607949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats.
    Vollmer U; Müller BW; Peeters J; Mesens J; Wilffert B; Peters T
    J Pharm Pharmacol; 1994 Jan; 46(1):19-22. PubMed ID: 8201522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further evaluation of a new penetration enhancer, HPE-101.
    Yano T; Higo N; Fukuda K; Tsuji M; Noda K; Otagiri M
    J Pharm Pharmacol; 1993 Sep; 45(9):775-8. PubMed ID: 7903363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of gel ointments containing tranilast nanoparticles on paw edema in adjuvant-induced arthritis rats.
    Nagai N; Ito Y
    Biol Pharm Bull; 2014; 37(1):96-104. PubMed ID: 24389486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The percutaneous penetration of prostaglandin E1 and its alkyl esters.
    Ho HO; Hwang MC; Tseng SL; Lin LH; Chen KT; Chiang HS; Spur BW; Wong PY; Sheu MT
    J Control Release; 1999 Apr; 58(3):349-55. PubMed ID: 10099159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minoxidil-containing dosage forms: skin retention and after-rinsing hair-growth promotion.
    Kim JC; Lee MH; Rang MJ
    Drug Deliv; 2003; 10(2):119-23. PubMed ID: 12746058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation into the mechanism by which cyclodextrins influence transdermal drug delivery.
    Kear CL; Yang J; Godwin DA; Felton LA
    Drug Dev Ind Pharm; 2008 Jul; 34(7):692-7. PubMed ID: 18608463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-performance liquid chromatographic assay of antiinflammatory drugs incorporated in gel ointments. Separation and stability testing.
    Yamamura K; Yamada J; Yotsuyanagi T
    J Chromatogr; 1985 Sep; 331(2):383-8. PubMed ID: 3932443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism studies on transdermal prostaglandin E1 in human foreskin in vitro.
    Foldvari M; Oguejiofor CJ
    Eur J Drug Metab Pharmacokinet; 1997; 22(2):111-20. PubMed ID: 9248778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gel ointment of verapamil for percutaneous absorption.
    Sekine T; Machida Y; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):245-52. PubMed ID: 3509338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic scleroderma patients have improved skin perfusion after the transdermal application of PGE1 ethyl ester.
    Schlez A; Häfner HM; Kittel M; Braun S; Diehm C; Jünger M
    Vasa; 2003 May; 32(2):83-6. PubMed ID: 12945100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-performance liquid chromatographic assay for prostaglandin E1 in various ointment vehicles. Separation and stability testing.
    Yamamura K; Yotsuyanagi T
    J Chromatogr; 1984 Oct; 303(1):165-72. PubMed ID: 6542568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of various marine lipids on transdermal drug delivery--in vitro evaluation.
    Loftsson T; Gunnarsdóttir T; Magnúsdóttir LM; Frioriksdóttir H; Guomundsdóttir TK; Olafsson JH; Haraldsson GG; Guomundsson G; Hjaltason B
    Boll Chim Farm; 1997 Nov; 136(10):640-5. PubMed ID: 9528172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin.
    Bond JR; Barry BW
    J Invest Dermatol; 1988 Jun; 90(6):810-3. PubMed ID: 3373011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of postherpetic neuralgia by topical application of prostaglandin E1-vaseline mixture--a single blind controlled clinical trial].
    Tamakawa S; Tsujimoto J; Iharada A; Ogawa H
    Masui; 1999 Mar; 48(3):292-4. PubMed ID: 10214018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.